Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

AMAVF - Downside Risk

|Includes:Arcam AB (AMAVF)

Arcam's client in the US Exatech has recalled their product produced with EBM

See FDA web page: http://www.drugwatch.com/hip-replacement/recalls/

Interesting in the light of the J&J settlement, where J&J has to pay $4bn for using metal in hip implants.

FDA comment: "All-metal implants can shed metallic debris, potentially damaging bone and soft tissue"

Arcam EBM has produced over 30.000 hip implants so far. J&J settlements was based on 7500 settlements.

Stocks: AMAVF